Fulcrum Equity Management Idexx Laboratories Inc Transaction History

Fulcrum Equity Management

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 15, 2022	SELL	$466.52 - $631.01 $1.13 Million - $1.53 Million	-2,422 Closed	0 $0
Q4 2021 Jan 25, 2022	SELL	$586.54 - $666.48 $53,961 - $61,316	-92 Reduced 3.66%	2,422 $1.6 Million
Q3 2021 Jan 25, 2022	SELL	$621.9 - $705.76 $561,575 - $637,301	-903 Reduced 26.43%	2,514 $1.56 Million
Q2 2021 Jul 15, 2021	SELL	$486.36 - $637.08 $386,169 - $505,841	-794 Reduced 18.86%	3,417 $2.16 Million
Q1 2021 Apr 05, 2021	BUY	$465.18 - $551.79 $7,908 - $9,380	17 Added 0.41%	4,211 $2.06 Million
Q4 2020 Feb 22, 2021	BUY	$383.85 - $499.87 $1.61 Million - $2.1 Million	4,194 New	4,194 $2.1 Million
Q4 2019 Feb 12, 2020	SELL	$248.66 - $285.01 $5,719 - $6,555	-23 Closed	0 $0
Q3 2019 Nov 05, 2019	BUY	$260.07 - $289.93 $5,981 - $6,668	23 New	23 $6,000

1,219

72.2M

155K

318K

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $37B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

Get notified when there are updates to the investment portfolio of Fulcrum Equity Management, based on Form 13F filings with the SEC.

Stay updated on Fulcrum Equity Management with notifications on news.